1,520
Views
6
CrossRef citations to date
0
Altmetric
Short Communications

Safety and effectiveness concerns of lopinavir/ritonavir in COVID-19 affected patients: a retrospective series

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 644-647 | Received 30 Aug 2020, Accepted 20 Oct 2020, Published online: 01 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Windi Fresha Qomara, Delya Nur Primanissa, Salma Hasni Amalia, Febby V Purwadi & Neily Zakiyah. (2021) Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review. International Journal of General Medicine 14, pages 8557-8571.
Read now

Articles from other publishers (5)

Jacqui P. Venturas. (2023) HIV and COVID-19 Disease. Seminars in Respiratory and Critical Care Medicine 44:01, pages 035-049.
Crossref
Felicia Marc, Corina Moldovan, Anica Hoza, Patricia Restea, Liliana Sachelarie, Laura Ecaterina Romila, Corina Suteu & Dorina Maria Farcas. (2021) Evaluation of Hepatic Biochemical Parameters during Antiviral Treatment in COVID-19 Patients. Biology 11:1, pages 13.
Crossref
Md. Jamal Hossain, Tabassum Jannat, Shejuti Rahman Brishty, Urmi Roy, Saikat Mitra, Md. Oliullah Rafi, Md. Rabiul Islam, Mst. Luthfun Nesa, Md. Ariful Islam & Talha Bin Emran. (2021) Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far. Biologics 1:2, pages 252-284.
Crossref
Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, S. M. Abdur Rahman & Isa Naina Mohamed. (2021) Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021. Frontiers in Pharmacology 12.
Crossref
. (2021) Lopinavir/ritonavir/sotalol. Reactions Weekly 1849:1, pages 272-272.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.